Sintx Technologies Inc (SINT)

$2.88 +0.03 (1.05%)
Market Cap 10.61M
Revenue (ttm) 2.89M
Net Income (ttm) -11.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -381.31%
Debt to Equity Ratio 0.01
Volume 30,200
Avg Vol 35,412
Day's Range N/A - N/A
Shares Out 3.68M
Stochastic %K 74%
Beta 0.67
Analysts Sell
Price Target $16.00

Company Profile

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and polyetherketoneketone. The company was formerly known as Am...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 839 3500
Address:
1885 West 2100 South, Salt Lake City, United States
Boston7452
Boston7452 Mar. 14 at 5:26 PM
$SINT I expect to see news soon that Sintx has invested in Ned Medical its Oncology partner. NED Medical has filed a notice of an exempt offering of securities to raise $11 Million in New Funding.
2 · Reply
Boston7452
Boston7452 Mar. 14 at 5:09 PM
$SINT is setup to work with companies like Zimmer Biomet and Solventum...maybe Boston Scientific for oncology?
2 · Reply
Boston7452
Boston7452 Mar. 14 at 4:59 PM
$SINT Then theres the implant side. Metal implants are poisoning people over time as those metal ions collect in their blood, organs (including brain), & tissue. To make matters worse, metal implants and those corroded ions, absorb/reflect natural/manmade EM Radiation making people sicker. Si3N4 coatings can reduce both these issues and completely replacing the implants with Si3N4 stops it all together.
2 · Reply
Boston7452
Boston7452 Mar. 14 at 4:52 PM
$SINT Case in point how its important for the future: Antiviral efficacy of silicon nitride against SARS-CoV-2 and MERS-CoV: implications for PPE innovation "Thus, silicon nitride could be an invaluable inorganic additive in personal protective equipment during future viral epidemics and pandemics."
1 · Reply
Boston7452
Boston7452 Mar. 14 at 3:14 PM
$SINT Snoop im not sure why youve framed that to be completely opposite but you could boil it down to enriching a specific few. Sintx has important tech for the future that is quite valuable and it seems people want to steal it for their own benefit. Thats essentially what Ive always been fighting against. The scope of whos involved in said conspiracy has grown from my perspective. Use to be just ansons conspiracy of funds i thought I was fighting against.
1 · Reply
SnoopyDog
SnoopyDog Mar. 14 at 10:35 AM
$SINT Boston telling very nice fairy tales on iHub. Worth to have a look if you want to have a good laugh on a lousy, rainy saturday. This guy never stops, but to be fair, its what he gets paid for...
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 3:32 AM
$SINT RSI: 35.25, MACD: -0.1050 Vol: 0.12, MA20: 2.89, MA50: 3.24 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SnoopyDog
SnoopyDog Mar. 12 at 4:31 PM
$SINT lol great predictions as usual
0 · Reply
SnoopyDog
SnoopyDog Mar. 12 at 10:01 AM
$SINT so exciting
0 · Reply
Love_To_Learn
Love_To_Learn Mar. 11 at 9:25 PM
$SINT MADE A LIL CHANGE TO U AS WELL * U WILL EXPERIENCE VOLATILITY SOON ISH
1 · Reply
Latest News on SINT
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Feb 18, 2026, 8:30 AM EST - 25 days ago

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

Jan 29, 2026, 9:00 AM EST - 6 weeks ago

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

Dec 1, 2025, 8:30 AM EST - 3 months ago

SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

Nov 3, 2025, 8:00 AM EST - 4 months ago

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Oct 20, 2025, 7:00 AM EDT - 5 months ago

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

Oct 14, 2025, 7:00 AM EDT - 5 months ago

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

Sep 8, 2025, 7:54 AM EDT - 6 months ago

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

Sep 8, 2025, 7:00 AM EDT - 6 months ago

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Aug 15, 2025, 7:00 AM EDT - 7 months ago

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

Aug 4, 2025, 7:00 AM EDT - 7 months ago

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

Jun 24, 2025, 8:30 AM EDT - 9 months ago

SINTX Technologies Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

May 22, 2025, 7:00 AM EDT - 10 months ago

SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

May 15, 2025, 7:05 AM EDT - 10 months ago

SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Feb 26, 2025, 8:00 AM EST - 1 year ago

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Feb 20, 2025, 6:15 AM EST - 1 year ago

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Feb 19, 2025, 6:00 AM EST - 1 year ago

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Nov 21, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Nov 19, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

SINTX Technologies Announces Stock Repurchase Program

Nov 18, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Announces Stock Repurchase Program

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

Nov 14, 2024, 6:00 AM EST - 1 year ago

SINTX Technologies Provides Positive Strategic Business Update for Q3 2024

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Oct 1, 2024, 8:00 AM EDT - 1 year ago

SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

Sep 20, 2024, 8:00 AM EDT - 1 year ago

Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Sep 9, 2024, 8:00 AM EDT - 1 year ago

SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

SINTX Technologies to Explore Strategic Opportunities

Jun 18, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies to Explore Strategic Opportunities

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

Jun 12, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

Jun 6, 2024, 9:00 AM EDT - 1 year ago

SINTX Technologies Receives Additional SBIR Contract for 3D Printing Technology

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

May 23, 2024, 9:00 AM EDT - 1 year ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE MAY 28, 2024

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

Apr 29, 2024, 9:14 AM EDT - 2 years ago

SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

Apr 3, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock

SINTX Technologies Announces Proposed Public Offering of Common Stock

Mar 29, 2024, 4:00 PM EDT - 2 years ago

SINTX Technologies Announces Proposed Public Offering of Common Stock

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Mar 25, 2024, 9:00 AM EDT - 2 years ago

SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

Feb 23, 2024, 7:50 AM EST - 2 years ago

Top 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)

GRI

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

Feb 21, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET

SINTX Technologies Announces Closing of $4.0 Million Public Offering

Feb 2, 2024, 2:33 PM EST - 2 years ago

SINTX Technologies Announces Closing of $4.0 Million Public Offering

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

Jan 31, 2024, 9:20 AM EST - 2 years ago

SINTX Technologies Announces Pricing of $4.0 Million Public Offering

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

Jan 30, 2024, 4:01 PM EST - 2 years ago

SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

Jan 23, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

Jan 4, 2024, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Nov 7, 2023, 9:00 AM EST - 2 years ago

SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

Nov 3, 2023, 8:28 AM EDT - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

ARQT HSCS

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

Oct 11, 2023, 9:00 AM EDT - 2 years ago

SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

Aug 17, 2023, 9:00 AM EDT - 2 years ago

3DCERAM SINTO INC. and SINTX TECHNOLOGIES ANNOUNCE COLLABORATION TO DEVELOP MATERIALS AND TECHNOLOGIES FOR ADDITIVE MANUFACTURING OF ADVANCED CERAMICS

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES ITS NEW UTAH ARMOR FACILITY IS FULLY OPERATIONAL

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

Feb 14, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Announces Its New Utah Armor Facility Is Fully Operational

SINTX Technologies Announces Closing of $12.0 Million Public Offering

Feb 10, 2023, 1:52 PM EST - 3 years ago

SINTX Technologies Announces Closing of $12.0 Million Public Offering

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

Feb 7, 2023, 9:05 PM EST - 3 years ago

SINTX Technologies Announces Pricing of $12.0 Million Public Offering

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

Jan 19, 2023, 9:00 AM EST - 3 years ago

SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

Jan 6, 2023, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

Dec 21, 2022, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE DECEMBER 20, 2022

Dec 19, 2022, 9:00 AM EST - 3 years ago

SINTX TECHNOLOGIES ANNOUNCES REVERSE STOCK SPLIT EFFECTIVE DECEMBER 20, 2022

Boston7452
Boston7452 Mar. 14 at 5:26 PM
$SINT I expect to see news soon that Sintx has invested in Ned Medical its Oncology partner. NED Medical has filed a notice of an exempt offering of securities to raise $11 Million in New Funding.
2 · Reply
Boston7452
Boston7452 Mar. 14 at 5:09 PM
$SINT is setup to work with companies like Zimmer Biomet and Solventum...maybe Boston Scientific for oncology?
2 · Reply
Boston7452
Boston7452 Mar. 14 at 4:59 PM
$SINT Then theres the implant side. Metal implants are poisoning people over time as those metal ions collect in their blood, organs (including brain), & tissue. To make matters worse, metal implants and those corroded ions, absorb/reflect natural/manmade EM Radiation making people sicker. Si3N4 coatings can reduce both these issues and completely replacing the implants with Si3N4 stops it all together.
2 · Reply
Boston7452
Boston7452 Mar. 14 at 4:52 PM
$SINT Case in point how its important for the future: Antiviral efficacy of silicon nitride against SARS-CoV-2 and MERS-CoV: implications for PPE innovation "Thus, silicon nitride could be an invaluable inorganic additive in personal protective equipment during future viral epidemics and pandemics."
1 · Reply
Boston7452
Boston7452 Mar. 14 at 3:14 PM
$SINT Snoop im not sure why youve framed that to be completely opposite but you could boil it down to enriching a specific few. Sintx has important tech for the future that is quite valuable and it seems people want to steal it for their own benefit. Thats essentially what Ive always been fighting against. The scope of whos involved in said conspiracy has grown from my perspective. Use to be just ansons conspiracy of funds i thought I was fighting against.
1 · Reply
SnoopyDog
SnoopyDog Mar. 14 at 10:35 AM
$SINT Boston telling very nice fairy tales on iHub. Worth to have a look if you want to have a good laugh on a lousy, rainy saturday. This guy never stops, but to be fair, its what he gets paid for...
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 3:32 AM
$SINT RSI: 35.25, MACD: -0.1050 Vol: 0.12, MA20: 2.89, MA50: 3.24 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SnoopyDog
SnoopyDog Mar. 12 at 4:31 PM
$SINT lol great predictions as usual
0 · Reply
SnoopyDog
SnoopyDog Mar. 12 at 10:01 AM
$SINT so exciting
0 · Reply
Love_To_Learn
Love_To_Learn Mar. 11 at 9:25 PM
$SINT MADE A LIL CHANGE TO U AS WELL * U WILL EXPERIENCE VOLATILITY SOON ISH
1 · Reply
amda
amda Mar. 11 at 7:38 PM
$SINT big buyer moving that bid up.....
0 · Reply
The_Gambl3r
The_Gambl3r Mar. 11 at 7:36 PM
$SINT 👀
0 · Reply
Boston7452
Boston7452 Mar. 11 at 6:13 PM
$SINT Woodland School in Traverse City closed Tuesday because of flu outbreak "The elementary school director, Rich Watson says at least 60 students are sick with the flu as of Monday. "
1 · Reply
Boston7452
Boston7452 Mar. 11 at 6:06 PM
$SINT Fears Australia could see another record flu season as 'Super-K' spreads "A fast-moving strain of influenza that has led to the deaths of dozens of children in the United States is evading the protective effects of past vaccines and community immunity, a new study has confirmed. The new and highly mutated strain of influenza A (H3N2), dubbed 'Super-K', was first detected in the USA in June last year and led to a summer surge of influenza in Australia. In January, 63 people died from influenza in Australia - roughly double the number seen in the same month in previous years."
0 · Reply
Boston7452
Boston7452 Mar. 11 at 6:00 PM
$SINT Im waiting for partnership announcements with Solventum and Zimmer Biomet.
0 · Reply
Boston7452
Boston7452 Mar. 11 at 4:05 PM
$SINT Thus they are either going to pump this at some point, IP worth over 1 billion, or they are going to try to force a transaction of some sort...which I dont suggest.
1 · Reply
Boston7452
Boston7452 Mar. 11 at 3:15 PM
$SINT Mgmt trades have been small individually but they add up to hundreds of thousands. Thats a large chunk of the float. Most of Sintx shares are held by specific investors, funds, mgmt. Leaving few shares available for retail to buy.
0 · Reply
amda
amda Mar. 11 at 1:39 PM
$SINT weird prints here this morning. slow nibbles on the ask with matching trades...
0 · Reply
SnoopyDog
SnoopyDog Mar. 11 at 5:25 AM
$SINT $SINT $SINT Just means no news on the horizon due to restrictions
0 · Reply
Boston7452
Boston7452 Mar. 10 at 8:14 PM
$SINT Isnt Lyons connected to Zimmer Biomet having helped sell Orthogrid to them in 2024?
1 · Reply
amda
amda Mar. 10 at 5:58 PM
$SINT $SINT insiders have traded $SINT stock on the open market 22 times in the past 6 months. Of those trades, 22 have been purchases and 0 have been sales. this is from a site called: Quiver Quantitative My comment: Mostly smaller purchases, but it sure looks like a trend...
0 · Reply
amda
amda Mar. 10 at 5:32 PM
$SINT Christopher Michael Lyons, a director of Sintx Technologies, Inc. (NASDAQ:SINT), has recently purchased shares of the company’s common stock. According to a Form 4 filing with the Securities and Exchange Commission, Lyons acquired a total of 8292 shares in two separate transactions for a total value of $24,092. The purchases were executed at prices ranging from $2.9 to $2.96 per share. Specifically, on February 25, 2026, Lyons bought 758 shares at $2.96 per share. This was followed by another purchase on March 2, 2026, where he acquired 7534 shares at $2.90 per share.
0 · Reply